Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-099617
Filing Date
2024-08-21
Accepted
2024-08-21 19:06:39
Documents
1
Period of Report
2024-08-19

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3831
  Complete submission text file 0000950170-24-099617.txt   5319
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Issuer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0100 Agricultural Production-Crops
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O ARCADIA BIOSCIENCES, INC. 202 COUSTEAU PLACE, SUITE 105 DAVIS CA 95618
Business Address
Comcowich Kevin (Reporting) CIK: 0001688770 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37383 | Film No.: 241229771